Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects

19Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Published data on the association between interleukin-10 (IL-10) gene polymorphisms and prostate cancer (PCa) are inconclusive. To derive a more precise estimation of the association, we conducted a meta-analysis. Data were collected from the following electronic databases: PubMed, Elsevier Science Direct, Excerpta Medica Database and Chinese Biomedical Literature Database, with the last report up to September 2010. The odds ratio (OR) and its 95% confidence interval (95%CI) were used to assess the strength of association. A total of 13 separate studies including 5503 cases and 6078 controls based on the search criteria were involved in this meta-analysis. Meta-analysis was performed for three IL-10 gene polymorphisms (rs1800896, rs1800871, and rs1800872). We found no association between IL-10 gene rs1800896 polymorphism and PCa in overall population (G versus A: OR = 1.00, 95%CI = 0.91-1.10, P = 0.99; AG + GG versus AA: OR = 1.18, 95%CI = 0.97-1.43, P = 0.10; GG versus AA + AG: OR = 1.04, 95%CI = 0.86-1.26, P = 0.67). In subgroup analysis, similar results were found in Caucasian (G versus A: OR = 0.99, 95%CI = 0.84-1.18, P = 0.92; AG + GG versus AA: OR = 1.32, 95%CI = 0.90-1.94, P = 0.16; GG versus AA + AG: OR = 1.07, 95%CI = 0.89-1.28, P = 0.48), and Asian (G versus A: OR = 0.97, 95%CI = 0.78-1.20, P = 0.78; AG + GG versus AA: OR = 1.07, 95%CI = 0.79-1.45, P = 0.65; GG versus AA + AG: OR = 1.24, 95%CI = 0.38-4.07, P = 0.73) populations. We did not detect an association between IL-10 gene rs1800871 polymorphism and PCa in overall population (T versus C: OR = 0.96, 95%CI = 0.85-1.08, P = 0.51; CT + TT versus CC: OR = 0.94, 95%CI = 0.80-1.11, P = 0.48; TT versus CC + CT: OR = 0.94, 95%CI = 0.81-1.10, P = 0.44). Similar results were found in Asian population (T versus C: OR = 0.85, 95%CI = 0.71-1.09, P = 0.09; CT + TT versus CC: OR = 0.72, 95%CI = 0.52-1.17, P = 0.05; TT versus CC + CT: OR = 0.89, 95%CI = 0.68-1.17, P = 0.39). We found no association between IL-10 gene rs1800872 polymorphism and PCa in overall population (A versus C: OR=1.03, 95%CI = 0.96-1.11, P = 0.41; CA + AA versus CC: OR = 1.04, 95%CI = 0.92-1.17, P = 0.56; AA versus CC + CA: OR = 1.02, 95%CI = 0.85-1.22, P = 0.87). Similar results were found in Caucasian population (A versus C: OR = 1.06, 95%CI = 0.98-1.16, P = 0.16; CA + AA versus CC: OR = 1.07, 95%CI = 0.85-1.35, P = 0.57; AA versus CC + CA: OR = 1.23, 95%CI = 0.92-1.64, P = 0.17). This meta-analysis suggests that there is no association between IL-10 gene rs1800896, rs1800871 and rs1800872 polymorphisms and PCa. © 2010 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Zou, Y. F., Wang, F., Feng, X. L., Tian, Y. H., Tao, J. H., Pan, F. M., & Huang, F. (2011). Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects. European Journal of Cancer, 47(7), 1072–1079. https://doi.org/10.1016/j.ejca.2010.11.034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free